NDC Package 67651-0224-0 Ranolazine

Tablet, Film Coated, Extended Release - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67651-0224-0
Package Description:
19800 TABLET, FILM COATED, EXTENDED RELEASE in 1 DRUM
Product Code:
Non-Proprietary Name:
Ranolazine
Substance Name:
Ranolazine
Usage Information:
Ranolazine is used to treat a certain type of chest pain (chronic stable angina). It decreases the number of times you may get chest pain. Relieving symptoms of angina can increase your ability to exercise and perform strenuous work. Ranolazine works differently than other drugs for angina, so it can be used with your other angina medications (including nitrates, calcium channel blockers such as amlodipine, beta blockers such as metoprolol). It is thought to work by improving how well the heart uses oxygen so that it can do more work with less oxygen.
11-Digit NDC Billing Format:
67651022400
Product Type:
Drug For Further Processing
Labeler Name:
Patheon Pharmaceuticals Inc.
Dosage Form:
Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
02-12-2007
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 67651-0224-0?

The NDC Packaged Code 67651-0224-0 is assigned to an UNFINISHED drug package of 19800 tablet, film coated, extended release in 1 drum of Ranolazine, drug for further processing labeled by Patheon Pharmaceuticals Inc.. The product's dosage form is tablet, film coated, extended release and is administered via form.

Is NDC 67651-0224 included in the NDC Directory?

Yes, Ranolazine is an UNFINISHED PRODUCT with code 67651-0224 that is active and included in the NDC Directory. The product was first marketed by Patheon Pharmaceuticals Inc. on February 12, 2007 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 67651-0224-0?

The 11-digit format is 67651022400. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-167651-0224-05-4-267651-0224-00